|Articles|September 16, 2009
- Fall 2009
- Volume 8
- Issue 3
CYP2D6 Inhibitors
Advertisement
>
Strong CYP2D6 Inhibitors* Paxil (paroxetine)
>
Prozac (fluoxetine)
>
Wellbutrin (bupropion)
>
Moderate CYP2D6 Inhibitors Cymbalta (duloxetine)
>
Zoloft (sertraline)
>
Weak CYP2D6 Inhibitors Celexa (citalopram)
>
Effexor (venlafaxine)
>
Lexapro (escitalopram)
Source: Abbreviated listing from Handbook of Essential Psychopharmacology, second edition, 2005
*To be avoided with tamoxifen
Articles in this issue
over 16 years ago
Web Exclusive: When is Multidisciplinary Care Really Needed?over 16 years ago
The Internal Flameover 16 years ago
Message from the Editorover 16 years ago
Letters from Our Readersover 16 years ago
Overheatedover 16 years ago
I Laughedover 16 years ago
Kidney Cancer & Lung Cancerover 16 years ago
Cancer Screeningover 16 years ago
Life Preserver?Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
From "Not Curable" to "May Be Curable": Joshua Richter, MD, on the New Reality of Multiple Myeloma
2
FDA Approves Welireg Plus Keytruda Combination for Adjuvant Treatment of Renal Cell Carcinoma
3
Why Cancer Survivorship Can Be the Hardest Part, Psychologist Says
4
A CAR-T Therapy Is Working Better Than Expected for Patients With Hard to Treat Leukemia
5